September 27, 2021
Overview: Evidation partnered with Sanofi to conduct a large-scale study to evaluate the effectiveness of a digitally administered intervention for increasing the influenza vaccination rate for people living with diabetes. It was found that personalized messaging for those living with chronic conditions, specifically diabetes, makes them more likely to receive vaccinations. Increasing flu vaccination is essential to protect vulnerable individuals, including those with chronic conditions, and communities while reducing strain on our health care system. With evidence-based, personalized interventions, individuals were able to achieve meaningful behavioral change.
Seasonal influenza, commonly called the flu, affects about 21 million people in the U.S. every year, resulting in significant burdens to the economy and public health. Vaccination remains the most effective way to reduce the risk of death or hospitalization, but the rate of vaccination consistently falls short of the goal of 70% set by national immunization guidelines for the U.S.
Recruitment, retention and adherence are important to the clinical trial process and outcomes, but biopharma companies have struggled with retaining trial participants. How can digital clinical trials personalize patient engagement and accelerate therapy development. READ MORE.
Can “nudging,” an intervention that changes people’s behaviors, improve the uptake of COVID-19 vaccines? Through text reminders for vaccine eligibility, vaccination rates and appointments went up by 1.65 and 1.06%. READ MORE.
FITBIT LAUNCHES NEWEST WEARABLE WITH STRESS MANAGEMENT FEATURES | MobiHealthNews
SOCIAL DETERMINANTS OF HEALTH AFFECT MOBILITY, DISABILITY STATUS | Patient Engagement HIT
STUDY: CANCER PATIENTS FRUSTRATED WITH SLOW RATE OF TREATMENT INNOVATIONS | Outsourcing-Pharma
APPLE’S HEALTH DATA SHARING FEATURE NOW LIVE | Healthcare IT News
THOUGHT LEADERSHIP: Myovant Sciences’ Kalahn Taylor-Clark addresses menstrual stigma and inequities. In a 2019 survey conducted by Evidation and Myovant, we confirmed periods are still stigmatized. 62% of the respondents who menstruate feel uncomfortable about their period. READ MORE.
RESEARCH: Nonadherence to medication and unwillingness to visit health facilities soar due to COVID-19. In April 2020, Evidation surveyed 1000+ individuals living with Rheumatoid Arthritis to understand how their disease management was impacted by the pandemic. READ MORE.
LIVE WEBINAR: You’re invited! Evidation is hosting a webinar with industry experts on how person-generated health data (PGHD) can revolutionize evidence generation from pre-clinical to post-market. Join us Oct. 13th at 1pm ET to discuss how to develop the right measures that are meaningful to patients. REGISTER HERE.
GET TO KNOW YOUR EVIDATION TEAM: Meet Vish Srivastava, Product Lead at Evidation Health who shares insights and lessons learned about his role on the product team. READ MORE.